Alfaro-Arnedo, E.; López, I.P.; Piñeiro-Hermida, S.; Ucero, Á.C.; González-Barcala, F.J.; Salgado, F.J.; Pichel, J.G.
Correction: Alfaro-Arnedo et al. IGF1R as a Potential Pharmacological Target in Allergic Asthma. Biomedicines 2021, 9, 912. Biomedicines 2022, 10, 733.
https://doi.org/10.3390/biomedicines10040733
AMA Style
Alfaro-Arnedo E, López IP, Piñeiro-Hermida S, Ucero ÁC, González-Barcala FJ, Salgado FJ, Pichel JG.
Correction: Alfaro-Arnedo et al. IGF1R as a Potential Pharmacological Target in Allergic Asthma. Biomedicines 2021, 9, 912. Biomedicines. 2022; 10(4):733.
https://doi.org/10.3390/biomedicines10040733
Chicago/Turabian Style
Alfaro-Arnedo, Elvira, Icíar P. López, Sergio Piñeiro-Hermida, Álvaro C. Ucero, Francisco J. González-Barcala, Francisco J. Salgado, and José G. Pichel.
2022. "Correction: Alfaro-Arnedo et al. IGF1R as a Potential Pharmacological Target in Allergic Asthma. Biomedicines 2021, 9, 912" Biomedicines 10, no. 4: 733.
https://doi.org/10.3390/biomedicines10040733
APA Style
Alfaro-Arnedo, E., López, I. P., Piñeiro-Hermida, S., Ucero, Á. C., González-Barcala, F. J., Salgado, F. J., & Pichel, J. G.
(2022). Correction: Alfaro-Arnedo et al. IGF1R as a Potential Pharmacological Target in Allergic Asthma. Biomedicines 2021, 9, 912. Biomedicines, 10(4), 733.
https://doi.org/10.3390/biomedicines10040733
